Growth factor receptor protein binding protein 2 (Grb2) is known to be associated with intracellular growth and proliferation related signaling cascades. Huntingtin (Htt), a ubiquitously expressed protein, when mutated, forms toxic intracellular aggregates - the hallmark of Huntington's disease (HD). We observed an elevated expression of Grb2 in neuronal cells in animal and cell models of HD. Grb2 overexpression was predominantly regulated by the transcription factor Forkhead Box D3 (Foxd3). Exogenous expression of Grb2 also reduced aggregation of mutant Htt in Neuro2A cells. Grb2 is also known to interact with Htt, depending on epidermal growth factor receptor (EGFR) activation. Grb2- mutant Htt interaction in the contrary, took place in vesicular structures, independent of EGFR activation that eventually merged with autophagosomes and activated the autophagy machinery helping in autophagosome and lysosome fusion. Grb2, with its emerging dual role, holds promise for a survival mechanism for HD.
Growth factor receptor protein binding protein 2 (Grb2) is known to be associated with intracellular growth and proliferation related signaling cascades. Huntingtin (Htt), a ubiquitously expressed protein, when mutated, forms toxic intracellular aggregates - the hallmark of Huntington's disease (HD). We observed an elevated expression of Grb2 in neuronal cells in animal and cell models of HD. Grb2 overexpression was predominantly regulated by the transcription factor Forkhead Box D3 (Foxd3). Exogenous expression of Grb2 also reduced aggregation of mutant Htt in Neuro2A cells. Grb2 is also known to interact with Htt, depending on epidermal growth factor receptor (EGFR) activation. Grb2- mutant Htt interaction in the contrary, took place in vesicular structures, independent of EGFR activation that eventually merged with autophagosomes and activated the autophagy machinery helping in autophagosome and lysosome fusion. Grb2, with its emerging dual role, holds promise for a survival mechanism for HD.
Several neurodegenerative diseases are caused by the increase in number of glutamine (polyQ) in specific genes, known as polyQ expansion diseases. Expansion of polyQ results in the formation of aggregates or insoluble inclusions. Huntington’s disease (HD), the most well studied amongst nine such neurodegenerative disorders, is caused by polyQ expansion in the protein huntingtin (Htt) [1]. In order to decipher the normal biological function of Htt, critical to the understanding of HD pathology, several groups have observed the localization of Htt in vesicles, ER and nuclei in various cell models [2-4] and the N-terminal 18 amino acids of Htt were reported to constitute the membrane targeting domain that mediated the association of Htt with ER and late endosomes [2].Growth factor receptor protein binding protein 2 (Grb2) is known to be an interactor of Htt and this interaction is reported to be regulated by the activation of epidermal growth factor (EGF) receptors [5]. The SH3 domains of this adaptor protein bind to the proline-rich regions of the guanine nucleotide releasing factor son of sevenless (SOS-1) and upon growth factor receptor activation and tyrosyl phosphorylation, they bring SOS-1 in close proximity of membrane bound Ras, eventually activating Ras and the downstream mitogen activated protein kinase (MAPK) cascade [6]. Grb2 is also involved in Rab5 mediated receptor endocytosis [7], a major pathway of epidermal growth factor receptor (EGFR) internalization in many cells [8]. In neurons, Grb2 is thought to link intracellular signaling cascades and activated receptor tyrosine kinases, like Trk receptors, and regulate neural survival, development, function, and plasticity [9]. It is suggested that Grb2-SOS-1 and Grb2-Htt are two different signaling complexes and since both Htt and SOS-1 bind to SH3, Htt acts as a competitor of the Ras-dependent signaling pathway [5]. Reports from transgenic and knockout animal models, protein-protein-interaction studies and the discovery of a plethora of Htt interactors suggest that Htt might act as a multifunctional scaffold during the process of clathrin-mediated endocytosis, neuronal transport processes and post synaptic signaling [10].In the present study, we have examined the cellular fate of Grb2-Htt interaction in the context of HD. We have shown that Grb2 is upregulated in both R6/2 mice and STHdhQ111/111 cell lines. While investigating the cause of Grb2 upregulation in HD model we found several transcription factor binding sites in the upstream DNA sequence of Grb2 and, through rational selection, checked the regulation of Grb2 by Forkhead Box D3 (Foxd3), a member of the forkhead box (Fox) family of transcription factors [11]. The Grb2 upregulation has been shown to be a consequence of overexpression of Foxd3. We have demonstrated how Grb2 could regulate the aggregation propensity of mutant Htt and the predominance of its interaction with mutant Htt in the absence of EGFR activation. Subsequent alterations in the downstream signaling pathways suggested the way by which Grb2 could be associated in clearing the toxic load of mutant Htt. The study clearly postulates an alternate possibility of prevention of aggregation and clearance of Htt in HD models.
Materials and Methods
Ethics Statement
All the animal related experiments were performed according to the protocol approved by the Institutional Animal Ethics Committee of National Brain Research Centre, Manesar. The animals had free access to pelleted diet and water ad libitum. All efforts were made to minimize animal suffering.
Plasmid Constructs
Details of plasmids, whether received as kind gift or described previously are given in supplementary material (File S1). For luciferase assay we cloned the 5’ upstream promoter region of mouseGrb2 gene from position -105 to -372 (encompassing the Foxd3 binding site from position -226 to -237) in pGL3 basic vector (designated as Luc-Grb2ups) between the restriction sites Xho1 and HindIII. The primer sequences used for this cloning are given in table S1 in File S2.
Bioinformatics Tools
Upstream sequence of the mouseGrb2 was downloaded from ENSEMBLE and NCBI and Transfac® MATCH1.0 public online search tool was used with default parameters to find out the binding sites for transcription factors in the given DNA sequence. We checked the expression levels of these hits obtained in the available microarray data for HD [12,13] using gene expression atlas.
R6/2 Mice
Ovarian transplanted hemizygote females carrying HD exon 1 gene with about 150 CAG repeats (strain name: B6CBATg (Hdexon1)62Gpb/3J) were purchased from Jackson Laboratory and crossed with B6CBAF1/J males. The transgenic strain was maintained by crossing the carrier males with CBA females. The genotyping was carried out using PCR as described previously by Mangirani et al., 1996 [14]. Age matched transgenic and wild type mice were used for all experiments as in [15]. The transgenic mice along with their age-matched controls were anesthetized and then perfused with PBS containing 4% PFA in PBS; brain samples were collected followed by cryosectioning with 20 mm thickness.
STHdhQ7/7 and STHdhQ111/111 cells
STHdhQ7/7 cells express full-length wild type HTT with 7Q (homozygous) while STHdhQ111/111 cells express full length mutated HTT with 111Q (homozygous) from the chromosomal region and is considered as models for HD. These cell lines were established from wild type and homozygous mutant Hdh knock in embryonic mice respectively [3]. Dr. Marcy E. MacDonald of Massachusetts General Hospital, USA, kindly gifted/donated these cells to us and they have published that STHdhQ111/111 cells exhibited dominant HD phenotypes and indicated a disruption of striatal cell homeostasis by the mutant HTT protein, via a mechanism that was different from its normal activity (STHdhQ7/7 cells) [3]. This cell model of HD has been extensively used for identifying molecular alterations in HD [13,16-21].
Cell Culture and transfection
Neuro 2A cells were procured from National Cell Science Centre (Pune, India) with proper licensing and routinely grown in DMEM (HiMedia, India) supplemented with 10% fetal bovine serum (Biowest, USA) at 37°C in 5% CO2 atmosphere under humidified condition as mentioned earlier [22-24]. Immortalized striatal HD cell lines, STHdhQ111/111 and STHdhQ7/7 cells [3] were grown in DMEM (HiMedia, India) supplemented with 10% FBS and 400µg/ml G418 (Invitrogen, USA) at 33°C in humidified condition and 5% CO2. Transfection of cells was performed using Lipofectamine TM2000 transfection reagent (Invitrogen, USA). In case of co-transfection, constructs were taken in equal proportions. After 48hrs, transiently transfected cells with (transfection efficiency varied between 70-90%) were checked for transfection efficiency by monitoring GFP or Dsred expression under fluorescence microscope and were used for experiments.
Antibodies and Chemicals
Chemicals and antibodies used in this study are described in File S1.
RNA preparation
Total RNA was prepared from cultured cells using TRIzol Reagent (Invitrogen, USA) according to manufacturer’s protocol. RNA samples were quantitated using nanodrop 2000 spectrophotometer (Thermo scientific, USA).
RNA Isolation from Mouse Tissue Samples
RNA isolation from mouse tissue samples was described previously [25] and is described in File S1.
Real Time PCR and Analysis
For real time PCR quantification of mRNAs 1 µg of total RNA was subjected to DNase (Sigma) treatment followed by cDNA preparation using random hexamer primer (Fermentas), dNTPs and MuLv- Reverse transcriptase (Fermentas) following the procedure described in [26]. Real time PCR was done in Applied Biosystems 7500 real time PCR system. Data show mRNA expression levels relative to those of beta-actin; the former was then normalized to control expression levels for each experiment.
Protein Extraction and Western Blot Analysis
Protein extraction protocol for western blot experiments from cell lines is described in supplementary material (File S1). The proteins from mice were prepared as described previously [15].
Immunoprecipitation Assay
Immunoprecipitation was done using anti-Grb2 or anti -Htt antibody from STHdhQ7/7 and STHdhQ111/111 cell extracts and anti–Grb2 antibody for Httex1 GFP transfected Neuro2A cell extracts. 50 µg of the whole cell extract was used as input in each experiment and 200 µg extract was incubated overnight with antibody and Protein A/G beads. After SDS–PAGE and western transfer, presence of Htt in the Grb2 interaction complex was revealed by immunoblotting with anti-Htt (CST, USA), anti–Grb2 (Abcam, USA) and anti-GFP (Roche, USA) antibodies respectively.
Knockdown of Grb2 by siRNA
Knockdown of Grb2 by gene specific siRNA in Neuro2A cells was described earlier [22]. Grb2 knockdown in STHdhQ7/7 and STHdhQ111/111 cells was done with the same siRNA. Grb2si and Grb2scrmbsi clones were transfected in STHdhQ111/111 cells using Lipofectamine 2000 (Invitrogen, USA) using a protocol provided by the manufacturer. Transfected cells were selected by hygromycin resistance. Knockdown of Grb2 was confirmed by western blot using anti-Grb2 antibody.
Confocal Microscopy
Imaging was performed on LSM 510 META confocal laser scanning microscope equipped with an argon-krypton laser (Carl Zeiss, Germany). Cells were grown on L-lysine coated cover slips, fixed with 4% paraformaldehyde and washed with PBS, mounted on slides and images were acquired in 63X oil immersion objective [27]. ImageJ software was used for the calculation of Pearson’s correlation coefficient and Intensity correlation quotient.
Aggregate Counting
Neuro2A cells were grown on coverslips in 35mm culture dish (Nunc, USA) transfected with 145Q Httex1 GFP and also cotransfected with Grb2-Dsred and Dsred as control and incubated for 48hr at 37°C. After 48hr of transfection coverslips were washed with PBS and mounted on slides for aggregate counting using confocal microscope (Carl Zeiss LSM 510 Meta, Germany). An average of 500 cells was counted for each slide and the experiments were done ten times.
Immunocytochemistry protocol is elaborated in File S1.
Fluorescence Lifetime Imaging Microscopy
Fluorescence Lifetime Imaging Microscopy (FLIM) was carried out using LSM510 META (Carl Zeiss) microscope and two photon Ti-Sapphire femtosecond pulsed laser Spectra Physics Mai-Tai at 940nm excitation wavelength with Becker & Hickl GmbH TCSPC FLIM module attachment (SPC-150 TCSPC module and DCC-100 detector) and images were analyzed using SPC Image 2.9.1 software.
Lysosomal Inhibition
BafilomycinA1 (Sigma, USA) was used as a lysosomal inhibitor for the assay. Cells were treated with 100nM of BafilomycinA1 and incubated for 12 hr and harvested for western blot analysis. Levels of LC3 were checked using western blot, which were normalized using the same of beta-actin.
Chromatin immunoprecipitation (ChIP) assay
Methods used for the ChIP experiments were described earlier [28] and also in File S1.
Filter Retardation Assay
Filter retardation assay was performed as described previously [27]. In brief, cells were lysed using 50 mm Tris–HCl (pH 8.0), 100 mm NaCl, 5 mm MgCl2, 0.5% NP-40 and protease inhibitor cocktail. Insoluble material was pelleted by centrifugation for 10 min at 18,000g at 4°C and were resuspended in 100 µl DNase I buffer [20 mm Tris–HCl (pH 8.0) and 15 mm MgCl2], and DNase I (Sigma, USA) was added to a final concentration of 0.5 mg/ml followed by incubation at 37°C for 1hr. Protein concentration was determined and the samples were diluted into 100 ml of 1% SDS and 50 mm DTT in PBS, boiled for 5 min; and filtered through a PVDF membrane using a BRL Hybrislot manifold. Two washes were performed with 200 µl of 0.1% SDS and then processed for immunodetection in the similar way of a regular western blot with anti-poly Q antibody (Chemicon, USA).
Luciferase Assay
The method for the luciferase assay was described previously [29].
MTT assay
MTT assay protocol is described previously [30], and is also discussed in File S1.
In-vivo Chaperone assay
Chaperone potential of Grb2 was tested by transfecting pGL3 basic vector into Neuro2A cells along with Grb2-Dsred, Hsp-70 GFP (positive control) or Dsred (negative control). 24hr. after transfection the cells were given heat-shock at 42°C for 1 hr followed by recovery at 37°C for 0hr, 2hr and 6hr respectively. Cells were lysed and luciferase assay was performed as described above. Increased luciferase activity suggests chaperone like potential of the transfected protein.
Grb2 purification
Briefly, Grb2-pET28a construct was transformed into BL21 (DE3) E. coli strain and grown until it reached 0.6 OD and then IPTG was used for induction following which the medium containing cells were incubated at 37°C. The cells were pelleted, lysed and sonicated and then His-tagged protein was purified using Ni-NTA resin (Qiagen, USA) and immidazole, according to manufacturer’s protocol. Protein fractions were checked for expression by running SDS-PAGE and fractions containing only purified Grb2 were used for further experiments.
In-vitro Chaperone Assay
Insulin aggregation assay was done as described previously [31], and is also mentioned in supplementary material (File S1).
Statistical Analysis
For statistical analysis, an unpaired ‘t’ test was carried out to compare the means of two experimental groups using the online software Graph Pad QuickCals available at Http://www.graphpad.com/quickcals/ttest.cfm. Statistical significance is shown with asterisks: * p ≤ 0.05; ** p ≤ 0.01, *** p≤ 0.001
Results
Grb2 is upregulated in Huntington’s disease Models
We checked the levels of endogenous Grb2 in STHdhQ111/111 and STHdhQ7/7 cells by western blot and the relative levels of endogenous Grb2 was found to be upregulated by about 1.5 folds in STHdhQ111/111 cells with respect to that of STHdhQ7 /7cells (Figure 1A,B p<0.01, n=3). Also mRNA levels of Grb2 was found to be upregulated in STHdhQ111/111 cells by about 5 fold (Figure 1C, p<0.001, n=3). We checked the levels of Grb2 mRNA and protein in age matched R6/2 mouse model of Huntington’s disease. R6/2 mice showed about 2.5 fold (Figure 1D; n=3, p<0.01) upregulation in mRNA level as well as 3 fold upregulation in protein level (Figure 1E,F, n=4, p<0.01) in striatum with respect to wild type mice. We transfected Httexon1GFP constructs with two polyQ lengths (23Q and 145Q) in Neuro2A cells and found Grb2 to be upregulated as a result of Httexon1 transfection (Figure 1 G,H; n=3, p<0.05). Although the differential expression of Grb2 between 23Q and 145Q Httexon1 transfected cells cannot be taken as significant (p=0.0506; n=3), despite a consistent transfection efficiency otherwise, the intensity of GFP in Htt145Qex1 transfected cells was less compared to that in Htt23Qex1 transfected cells nonetheless.
Figure 1
Grb2 is upregulated and is regulated by Foxd3 in Huntington’s disease condition
A. Representative Western blot of three (n=3) independent experiments for Grb2 and beta actin expression in STHdhQ7/7 and STHdhQ111/111 cells. Expression of beta actin was taken as internal control. B. Bar diagram representing the mean optical density of bands obtained in A normalized to that of beta actin (p< 0.01). C. Normalized fold changes of Grb2 and Foxd3 mRNA levels of three independent real time PCR experiments in STHdhQ111/111 with respect to STHdhQ7/7, beta actin taken as internal control (n=3, p<0.001, and p<0.01 respectively). D. Grb2 and Foxd3 normalized fold change mRNA expression levels in striatum tissues of wild type and R6/2 age matched mice, beta actin taken as internal control. Data of three independent experiments (Grb2; p<0.01; Foxd3 p<0.01, n=3). E. Western blot showing Grb2, Foxd3 and beta actin levels in striatum tissues of age matched control and R6/2 mice F. Bar diagram of four (n=4; Grb2 p<0.01; Foxd3 p<0.001) independent samples as shown in E. G. Western blot representative picture of GFP, Grb2, Foxd3 and beta actin (loading control) expression levels in Neuro2A cells transfected with GFP, 23Q Httex1 and 145QHttex1 GFP respectively. H. Bar diagram of expression levels of Grb2 and Foxd3 normalized to that of beta actin as shown in panel H. of three independent experiments (p<0.05,n=3). I. Luciferase reporter assay (n=3) of the Grb2 upstream sequence cloned in pGL3 vector in empty GFP transfected STHdhQ7/7 and GFP transfected STHdhQ111/111 cells. Luciferase activity of above cells was normalized by the luciferase activity of the corresponding empty pGL3 vector transfected cells (p<0.001). J. Comparative ChIP analysis showing relative occupancy of endogenous Foxd3 in Grb2 promoter was more in STHdhQ111/111 cells compared to STHdhQ7/7 cells. Immunoprecipitation was carried out with anti-Foxd3 antibody and the immunoprecipitated DNA was PCR amplified using primers specific for Grb2 upstream sequence (n=3). K. Bar diagram of normalized fold change of intensity of immunoprecipitated DNA as shown in panel J. Data of three independent experiment (n=3, p<0.05). L. Representative agarose gel picture of ChIP analysis (n=3) showing occupancy of endogenous Foxd3 in Grb2 promoter in Neuro2A cell.
Grb2 is upregulated and is regulated by Foxd3 in Huntington’s disease condition
A. Representative Western blot of three (n=3) independent experiments for Grb2 and beta actin expression in STHdhQ7/7 and STHdhQ111/111 cells. Expression of beta actin was taken as internal control. B. Bar diagram representing the mean optical density of bands obtained in A normalized to that of beta actin (p< 0.01). C. Normalized fold changes of Grb2 and Foxd3 mRNA levels of three independent real time PCR experiments in STHdhQ111/111 with respect to STHdhQ7/7, beta actin taken as internal control (n=3, p<0.001, and p<0.01 respectively). D. Grb2 and Foxd3 normalized fold change mRNA expression levels in striatum tissues of wild type and R6/2 age matched mice, beta actin taken as internal control. Data of three independent experiments (Grb2; p<0.01; Foxd3 p<0.01, n=3). E. Western blot showing Grb2, Foxd3 and beta actin levels in striatum tissues of age matched control and R6/2 mice F. Bar diagram of four (n=4; Grb2 p<0.01; Foxd3 p<0.001) independent samples as shown in E. G. Western blot representative picture of GFP, Grb2, Foxd3 and beta actin (loading control) expression levels in Neuro2A cells transfected with GFP, 23Q Httex1 and 145QHttex1 GFP respectively. H. Bar diagram of expression levels of Grb2 and Foxd3 normalized to that of beta actin as shown in panel H. of three independent experiments (p<0.05,n=3). I. Luciferase reporter assay (n=3) of the Grb2 upstream sequence cloned in pGL3 vector in empty GFP transfected STHdhQ7/7 and GFP transfected STHdhQ111/111 cells. Luciferase activity of above cells was normalized by the luciferase activity of the corresponding empty pGL3 vector transfected cells (p<0.001). J. Comparative ChIP analysis showing relative occupancy of endogenous Foxd3 in Grb2 promoter was more in STHdhQ111/111 cells compared to STHdhQ7/7 cells. Immunoprecipitation was carried out with anti-Foxd3 antibody and the immunoprecipitated DNA was PCR amplified using primers specific for Grb2 upstream sequence (n=3). K. Bar diagram of normalized fold change of intensity of immunoprecipitated DNA as shown in panel J. Data of three independent experiment (n=3, p<0.05). L. Representative agarose gel picture of ChIP analysis (n=3) showing occupancy of endogenous Foxd3 in Grb2 promoter in Neuro2A cell.
Foxd3 predominantly regulates the transcription of Grb2
While investigating for molecular players behind Grb2 transcriptional upregulation, we used Transfac® MATCH1.0 public online search tool for probable binding sites of transcription factors in the 10Kb upstream DNA sequence of Grb2 and found 30 probable binding sites for 19 different transcription factors (see Tables S2 and S3 in File S2). Of these only 6 were known to be differentially expressed in HD [12,13] and only 3 have binding sites within 1Kb DNA sequence upstream to Grb2. Combining these two selection criteria, only Foxd3 and HNF-3beta/Foxa2 came out to be two probable candidates for the regulation, of which Foxd3was chosen for our study. In STHdhQ111/111 cells the expression of Foxd3, member of forkhead box transcription factor, having a binding site at -226 to -237 upstream of Grb2, was found to be upregulated by 2 folds (Figure 1C, n=3; p<0.01). In age matched R6/2 miceFoxd3 was upregulated in striatum by 1.5 fold (Figure 1D, n=3, p<0.01) at the mRNA level and 2 fold at the protein (Figure 1E, F, n=4, p<0.001) level. Consequently Foxd3 was also upregulated when Neuro2A cells were transfected with Htt exon1 (23Q, 145Q) GFP (Figure 1 G, H; n=3, p<0.05). Here also the differential expression of Foxd3 between 23Q and 145Q Httexon1 transfected cells (p=0.1056; n=3) was not significant, despite a consistent transfection efficiency otherwise, and the intensity of GFP in 145QHttexon1 transfected cells was diminished compared to the other.Luc-Grb2ups Foxd3 binding site was transfected both in STHdhQ7/7 and STHdhQ111/111 cells and it showed 2 fold enhanced luciferase signal in case of the latter, indicating that the promoter activation by Foxd3 was higher in the latter cell type due to the upregulation of Foxd3 (Figure 1I, p<0.001, n=3). Chromatin immunoprecipitation (ChIP) assay was then used to validate actual binding of Foxd3 to the upstream nucleotide sequence of the gene Grb2. We immunoprecipitated the crosslinked nuclear extract from both the cells with anti-Foxd3 antibody and did PCR with Grb2ups specific primers. The intensity of DNA bands in agarose gel electrophoresis (Figure 1 J, K), indicated about 4 fold higher (n=3; p<0.05) immunoprecipitation in case of STHdhQ111/111 cells. Similar positive bands were observed in ChIP with Neuro2A nuclear fraction (Figure 1L, n=3).
Upregulated Grb2 interacts with Htt in a polyQ dependent manner and deviates from its normal function
To ascertain the effects of enhanced level of Grb2 in STHdhQ111/111, under the transcriptional regulation of Foxd3, downstream signaling pathways of Grb2 were investigated. The activity levels of MAPK signaling molecules like ERK1/2 and JNK1/2 were assayed in terms of their extent of phosphorylation. Interestingly, phospho ERK1/2 (Figure 2A, B; p<0.001, n=3) and phospho JNK1/2 (Figure 2A, B p<0.001; n=3) levels were found to be downregulated significantly despite the upregulation of Grb2. In order to find out where this extra Grb2 was going, we investigated the levels of autophagy related proteins in STHdhQ111/111 cells and the two autophagy markers LC3, Beclin1 and late endosomal marker Rab7 were found to be significantly upregulated in the HD cell model (Figure 2C,D; p<0.01; n=3; for all).
Figure 2
Upregulated Grb2 interacts with mutant Htt and deviates from its normal function
A. Western blot analysis for the expression of phospho ERK1/2, ERK1/2, phospho JNK1/2, JNK1/2, phospho p38, p38 and beta actin levels in STHdhQ7/7 and STHdhQ111/111 cells. B. Bar diagram of densitometric analysis for three independent (n=3) experiments as shown in panel A the values of phospho ERK1/2 was normalized to that of total ERK1/2 levels, phospho JNK1/2 was normalized to total JNK and phospho p38 level was normalized to that of total p38 level (for pERK1/2 and pJNK1/2 ;p<0.001). C. Western blot analysis for the expression of LC3, beclin1, Atg5, Rab7 and beta actin in STHdhQ7/7 and STHdhQ111/111 cells. D. Bar diagram of densitometric analysis of three (n=3) different experiments as shown in panel C, beta actin taken as internal control (p<0.01 for LC3 and Beclin1, p<0.05 for Rab7). E. Immunoprecipitation experiment (n=3) of Grb2 with Htt in STHdhQ7/7 and STHdhQ111/111 cells. Cell extract was pulled with anti-Grb2 antibody and the pulled down protein was probed with Htt antibody in 6% SDS-PAGE and for the pulled Grb2 was run in 12% SDS-PAGE with same sample and probed with anti Grb2 antibody. F. Immunoprecipitation experiment (n=3) of Grb2 with Htt in STHdhQ7/7 and STHdhQ111/111 cells. Cell extract was pulled with anti-Htt antibody and the pulled down protein was probed with anti Grb2 antibody in 12% SDS-PAGE and for the pulled Htt was run in 6% SDS-PAGE with same sample and probed with anti Htt antibody G. Immunoprecipitation experiment (n=3) with Neuro2A cells transfected with 23Q and 145Q Httex1 GFP respectively and pulled with anti-Grb2 antibody, probed with anti GFP antibody. H. Bar diagram of densitometric analysis of three independent (n=3) as shown in panel G.
Upregulated Grb2 interacts with mutant Htt and deviates from its normal function
A. Western blot analysis for the expression of phospho ERK1/2, ERK1/2, phospho JNK1/2, JNK1/2, phospho p38, p38 and beta actin levels in STHdhQ7/7 and STHdhQ111/111 cells. B. Bar diagram of densitometric analysis for three independent (n=3) experiments as shown in panel A the values of phospho ERK1/2 was normalized to that of total ERK1/2 levels, phospho JNK1/2 was normalized to total JNK and phospho p38 level was normalized to that of total p38 level (for pERK1/2 and pJNK1/2 ;p<0.001). C. Western blot analysis for the expression of LC3, beclin1, Atg5, Rab7 and beta actin in STHdhQ7/7 and STHdhQ111/111 cells. D. Bar diagram of densitometric analysis of three (n=3) different experiments as shown in panel C, beta actin taken as internal control (p<0.01 for LC3 and Beclin1, p<0.05 for Rab7). E. Immunoprecipitation experiment (n=3) of Grb2 with Htt in STHdhQ7/7 and STHdhQ111/111 cells. Cell extract was pulled with anti-Grb2 antibody and the pulled down protein was probed with Htt antibody in 6% SDS-PAGE and for the pulled Grb2 was run in 12% SDS-PAGE with same sample and probed with anti Grb2 antibody. F. Immunoprecipitation experiment (n=3) of Grb2 with Htt in STHdhQ7/7 and STHdhQ111/111 cells. Cell extract was pulled with anti-Htt antibody and the pulled down protein was probed with anti Grb2 antibody in 12% SDS-PAGE and for the pulled Htt was run in 6% SDS-PAGE with same sample and probed with anti Htt antibody G. Immunoprecipitation experiment (n=3) with Neuro2A cells transfected with 23Q and 145Q Httex1 GFP respectively and pulled with anti-Grb2 antibody, probed with anti GFP antibody. H. Bar diagram of densitometric analysis of three independent (n=3) as shown in panel G.The interaction between Grb2 and Htt was first confirmed by immunoprecipitation in both STHdhQ7/7 and STHdhQ111/111 cells. We pulled down the whole cell extracts by anti-Grb2 antibody and probed with anti-Htt antibody. We found that in STHdhQ111/111 cells Htt was indeed pulled down by Grb2 but not in STHdhQ7/7 indicating that the interaction between Grb2 and Htt was polyQ dependent (Figure 2 E, n=3). We confirmed this data by reverse pull down by anti-Htt-antibody and probing with anti-Grb2-antibody and we observed Grb2 being pulled down in case of STHdhQ111/111 but not in STHdhQ7/7 (Figure 2F, n=3) as expected. Since full length Htt is of very high molecular weight (around 350 kDa) and Grb2 being around 27 kDa it was impossible to probe both the molecules in the same gel. So Htt was probed in 6% SDS-PAGE and Grb2 in 12% SDS-PAGE with equal amounts of same samples. We also transfected Neuro2A cells with 23Q and 145Q Httexon1 GFP and immunoprecipitated with anti-Grb2 antibody and probed the immunoblot with anti-GFP antibody. We found about 2 fold higher precipitation in case of the mutant 145Q Httex1 GFP (Figure 2G, H, n=3, p<0.05). Clearly in the HD cell model, Grb2 has been digressed from its natural signal transduction role.
Elevated level of Grb2 reduces Htt Aggregation and shows chaperone like activity
We studied the interaction of Htt exon1-Grb2 and its consequences in Neuro2A cells by confocal imaging. Two different forms of GFP fused Htt exon1 clones [23Q Htt exon1 GFP (23QHttex1GFP) and 145Q Htt exon1 GFP (145QHttex1GFP) respectively] were used with different polyQ repeats in the constructs. Full length Grb2 was expressed as a fusion product with red fluorescent protein Dsred (Grb2-Dsred) (Figure 3A). 23QHttex1GFP, when expressed alone, was found to be uniformly distributed in the cytoplasm, whereas 145QHttex1GFP, when expressed alone, was found to form aggregates inside the cells in addition to its ubiquitous expression throughout (Fig 3Ai.). Grb2-Dsred when expressed alone was localized in spherical structures (Fig. 3Ai), previously identified by us as late endosomal vesicles [22]. Surprisingly, we found that double transfected Neuro2A cells expressing both Grb2-Dsred and 145QHttex1GFP did not form any visible aggregates. In Neuro2A cells 145QHttex1GFP was also localized in vesicular structures (Fig.3Aiv) and found to colocalize with Rab7 (Figure S1 in File S2), a late-endosomal marker, along with Grb2 in addition to its ubiquitous expression in the cytosol. The average intensity of the GFP signal in vesicles was significantly higher than that in the cytoplasm and the protein was found to be colocalized with Grb2-Dsred inside the vesicles. The number of cells having aggregates was found to be significantly reduced in the double transfected Htt-Grb2 cells with respect to single transfected cells expressing 145QHttex1GFP (p<0.001; n=10; Figure 3B). In case of 23QHttex1GFP and Grb2-Dsred double transfected cells no such co-localization between Htt and Grb2 was observed (Fig. 3Avii).
Figure 3
Grb2 reduces Htt exon 1 aggregates in Neuro2A cell
A. Representative confocal images of Neuro2A cells transfected with i. 145QHttex1 GFP, i.Grb2-Dsred (Grb2 cloned in DsredC1 vector), ii. Double transfection with Htt 145QHttex1GFP and DsredC1 empty vector, iii. Double transfection of GFP empty vector and Grb2-Dsred, iv. Double transfection of 145Q Httex1 GFP and Grb2-Dsred, v. 23QHttex1 GFP and Grb2-Dsred again, vi.double transfection of 23QHttex1 GFP and DsredC1 empty vector and vii. Double transfection of 23QHttex1 GFP with Grb2-Dsred. All images were taken in same magnification. B. Bar diagram of percentage of Neuro2A cells having aggregates transfected with 145Q Httex1 GFP, co-transfection of 145QHttex1 GFP and empty vector DsredC1 and reduced percentage of cells with aggregates in co-transfection of 145QHttex1 GFP with Grb2-Dsred (n=10, p<0.001). C. Relative fluorescence index (RFI) of 145QHttex1 GFP pre- and post bleaching in cells transfected with 145QHttex1 GFP, co-transfected with 145Q Httex1 GFP and Dsred empty vector and cells co-transfected with 145Q Httex1 GFP with Grb2-Dsred. D. Representative image for filter retardation assay with Neuro2A cells transfected with Grb2-Dsred, 145Q Httex1 GFP double transfected with 145Q Httex1 GFP with Grb2-Dsred and double transfected with 145QHtt ex 1 GFP with Dsred. For all the samples input loads of 20µg and 40µg were used.
Grb2 reduces Htt exon 1 aggregates in Neuro2A cell
A. Representative confocal images of Neuro2A cells transfected with i. 145QHttex1 GFP, i.Grb2-Dsred (Grb2 cloned in DsredC1 vector), ii. Double transfection with Htt 145QHttex1GFP and DsredC1 empty vector, iii. Double transfection of GFP empty vector and Grb2-Dsred, iv. Double transfection of 145Q Httex1 GFP and Grb2-Dsred, v. 23QHttex1 GFP and Grb2-Dsred again, vi.double transfection of 23QHttex1 GFP and DsredC1 empty vector and vii. Double transfection of 23QHttex1 GFP with Grb2-Dsred. All images were taken in same magnification. B. Bar diagram of percentage of Neuro2A cells having aggregates transfected with 145Q Httex1 GFP, co-transfection of 145QHttex1 GFP and empty vector DsredC1 and reduced percentage of cells with aggregates in co-transfection of 145QHttex1 GFP with Grb2-Dsred (n=10, p<0.001). C. Relative fluorescence index (RFI) of 145QHttex1 GFP pre- and post bleaching in cells transfected with 145QHttex1 GFP, co-transfected with 145Q Httex1 GFP and Dsred empty vector and cells co-transfected with 145Q Httex1 GFP with Grb2-Dsred. D. Representative image for filter retardation assay with Neuro2A cells transfected with Grb2-Dsred, 145Q Httex1 GFP double transfected with 145Q Httex1 GFP with Grb2-Dsred and double transfected with 145QHtt ex 1 GFP with Dsred. For all the samples input loads of 20µg and 40µg were used.Grb2-Dsred and 145QHttex1-GFP containing structures, despite having colocalization with Rab7, did not have resemblance with classical late endosomal vesicles. Grb2 was not any aggregate prone protein to our knowledge. To verify whether these structures were protein inclusion bodies or actually vesicles, we did Fluorescence recovery after photobleaching (FRAP) and filter retardation assay. Fluorescence recovery after photobleaching (FRAP) experiment was performed to investigate the mobility of the mutant Htt (145QHttex1GFP), in this case the one with the bigger polyQ stretch. Htt aggregates in single transfected cells with 145QHttex1 GFP, when bleached, failed to recover their fluorescence. But in cells co-transfected with 145QHtt GFP and Grb2-Dsred, full recovery of 145QHttex1GFP signals was observed after photobleaching after bleaching at vesicular structures (Figure 3C). Additionally, filter retardation assay showed no SDS insoluble aggregates or inclusion bodies in Grb2-Dsred transfected Neuro2A cells at both 20µg and 40µg protein loads but 145QHttex1 GFP transfected and 145QHttex1 GFP and Dsred double transfected cells showed visible aggregates in both 20 µg and 40 µg loads. In 145QHttex1 GFP and Grb2-Dsred transfected cells the band was merely visible at 40 µg input and no band was visible at 20 µg protein input (Figure 3D and Figure S2 in File S2). The data unequivocally indicated increased protein mobility of 145QHttex1 GFP in presence of enhanced proportions of Grb2-Dsred, suggesting a quantitative reduction of Htt aggregates in presence of the latter. The natural conclusion from these observations, that Grb2 could possess chaperone like potential, was checked by in-vivo and in-vitro chaperone assays. Grb2-Dsred showed significantly higher (Figure 4A, p<0.01, n=3) recovery with respect to cells transfected with only pGL3 or pGL3 and Dsred. Hsp70-GFP was taken as a positive control for this experiment.
Figure 4
Localized interaction between Htt and Grb2 and Chaperone potential of Grb2
A. Normalized fold change of luciferase signal of cells transfected with pGL3 basic vector, pGL3 vector plus Dsred empty vector, pGL3 basic vector plus Grb2-Dsred and pGL3 vector plus Hsp70 GFP, all of the cells given heat shock for 1 hour and recovery at 37°C for 0hr, 2hr and 6hr. Fold change was calculated taking no heat shock cells as a control. B. Change in relative absorbance at 360nm with time was plotted for insulin with DTT alone or, in presence of 0.3mg/ml BSA, 0.3mg/ml Grb2, and 0.3mg/ml Hsp70. C. Fluorescence lifetime images of 145Q Httex1 GFP in cells transfected with i. 145Q Httex1 GFP, ii. co-transfected with 145Q Httex1 GFP and Grb2-Dsred and iii.co-transfected with 145Q Httex1 GFP and DsredC1. D. Fluorescence lifetime images of 23Q Httex1 GFP in cells transfected with i. 23Q Httex1 GFP, ii. Co-transfected with 23Q Httex1 GFP and Grb2-Dsred C and iii. co-transfected with 23Q Httex1 GFP and DsredC1. E. Analysis of cells co-transfected with 145Q Httex1 GFP and Grb2-Dsred i. a1/a2 image shows the ratio of interacting and non interacting species within the cell, ii and iii (normalized and not normalized images respectively) shows τ1/τ2 images in different scales showing the ratio of GFP two lifetime species within the cell.
Localized interaction between Htt and Grb2 and Chaperone potential of Grb2
A. Normalized fold change of luciferase signal of cells transfected with pGL3 basic vector, pGL3 vector plus Dsred empty vector, pGL3 basic vector plus Grb2-Dsred and pGL3 vector plus Hsp70 GFP, all of the cells given heat shock for 1 hour and recovery at 37°C for 0hr, 2hr and 6hr. Fold change was calculated taking no heat shock cells as a control. B. Change in relative absorbance at 360nm with time was plotted for insulin with DTT alone or, in presence of 0.3mg/ml BSA, 0.3mg/ml Grb2, and 0.3mg/ml Hsp70. C. Fluorescence lifetime images of 145Q Httex1 GFP in cells transfected with i. 145Q Httex1 GFP, ii. co-transfected with 145Q Httex1 GFP and Grb2-Dsred and iii.co-transfected with 145Q Httex1 GFP and DsredC1. D. Fluorescence lifetime images of 23Q Httex1 GFP in cells transfected with i. 23Q Httex1 GFP, ii. Co-transfected with 23Q Httex1 GFP and Grb2-Dsred C and iii. co-transfected with 23Q Httex1 GFP and DsredC1. E. Analysis of cells co-transfected with 145Q Httex1 GFP and Grb2-Dsred i. a1/a2 image shows the ratio of interacting and non interacting species within the cell, ii and iii (normalized and not normalized images respectively) shows τ1/τ2 images in different scales showing the ratio of GFP two lifetime species within the cell.Insulin aggregation assay, a well known assay for assessing chaperone action of a protein [31] was used to check the chaperone like activity of purified Grb2. Mutant Htt, being aggregation prone, could not be purified in-vitro. In-vitro insulin aggregation was induced by adding DTT to it and light scattering at 360nm was monitored for 50 mins. In presence of purified His-tagged Grb2 the scattering for insulin aggregation was lower than that in presence of BSA but it was higher than that of Hsp70 (Figure 4B).
Interaction between mutant Htt and Grb2 takes place within vesicles
Given that Grb2 directly influenced the aggregation state of Htt, we wanted to know exactly where did they cross-talk and time correlated single photon counting (TCSPC) based Fluorescence lifetime imaging (FLIM) techniques were used to check Förster resonance energy transfer (FRET) between the two molecules in Neuro2A cells. Two photon excitation femtosecond pulsed laser was used to detect GFP lifetime. The clones used were standard FRET donor-acceptor pair (GFP donor and Dsred acceptor). The lifetime map of double transfected cells revealed strong reduction of GFP lifetime in vesicular bodies (Figure S1 in File S2) inside cells (Figure 4C panel ii) indicating proximity of the molecules within Förster distance. No such reduction in GFP lifetime was observed in control experiments with empty vectors (cells co-transfected with 145QHttex1 GFP and Dsred) (Figure 4C panel i and iii). The distribution of the ratio of interacting and non interacting components of 145QHttex1 GFP in the cell (a1/a2) and the ratio of the two GFP species having different lifetimes across the cell (τ1/τ2) are shown in Figure 4E(i and ii, iii) respectively. The lifetime image of 23QHttex1 GFP co-transfected with Grb2-Dsred did not show any such reduction in GFP lifetime (Figure 4D, ii). The results strongly depicted that Htt-Grb2 interaction was being carried out in vesicular structures (Figure S1 in File S2) inside cells.
Grb2 helps in Htt clearance by evoking lyso-autophagy pathway and elicits autophagosome-lysosome fusion
To understand any correlation between the vesicular localization of Htt-Grb2 interaction and consequent rise in the levels of autophagy markers (also previously reported in some HD models [32]), Grb2 was knocked down in both STHdhQ7/7 and STHdhQ111/111 cells using RNAi molecules, which showed downregulation of LC3 (Figure 5A, C, p<0.001 and p<0.05, n=3 respectively) and pERK1/2 (Figure 5A, B p<0.001 for both, n=3). When the same was overexpressed in STHdhQ7/7 and STHdhQ111/111 cells by Grb2-Dsred transfection, expression of pERK1/2 was upregulated (Figure 5A, B, p<0.01 for both, n=3) and that of LC3 was marginally upregulated (Figure 5A, C p<0.01 for STHdhQ7/7, n=3).
Figure 5
Grb2 helps in Htt clearance via lyso-autophagy pathway and also in autophagosome fusion with Lysosome
A. Western blot analysis of expression of Grb2, pERK1/2, total ERK, LC3 and beta actin in STHdhQ7/7, STHdhQ7/7 transfected with Grb2-Dsred, STHdhQ7/7 transfected with Dsred, STHdhQ7/7 Grb2si, STHdhQ7/7 Scrmbsi, STHdhQ111/111 transfected with Grb2-Dsred, STHdhQ111/111 transfected with Dsred, STHdhQ111 /111Grb2si and STHdhQ111/111 Scrmbsi cells. B. Bar diagram of pERK1/2 levels of three experiments (n=3) as shown in panel A. normalized to total ERK1/2 levels. C. Bar diagram of LC3 II levels of three experiments (n=3) as shown in panel A normalized to beta actin levels. D. Representative confocal images of STHdhQ7/7, STHdhQ111/111, STHdhQ111 /111Grb2si, STHdhQ111/111 Scrmbsi cells transfected with dual tagged GFP-LC3-mCherry at 24hrs, 48hrs, 72hrs and 96hrs timepoints. E. Bar diagram of ratio of number of green/red to free red vesicles in each cell of D (n≥20). F. Representative western blot showing LC3 and beta actin levels of STHdhQ7/7, STHdhQ111/111 and STHdhQ111 /111Grb2si cells treated or untreated with 100nM bafilomycinA1, G. Bar diagram of three independent (n=3) experiments of F. of LC3II levels normalized to beta actin levels.
Grb2 helps in Htt clearance via lyso-autophagy pathway and also in autophagosome fusion with Lysosome
A. Western blot analysis of expression of Grb2, pERK1/2, total ERK, LC3 and beta actin in STHdhQ7/7, STHdhQ7/7 transfected with Grb2-Dsred, STHdhQ7/7 transfected with Dsred, STHdhQ7/7 Grb2si, STHdhQ7/7 Scrmbsi, STHdhQ111/111 transfected with Grb2-Dsred, STHdhQ111/111 transfected with Dsred, STHdhQ111 /111Grb2si and STHdhQ111/111 Scrmbsi cells. B. Bar diagram of pERK1/2 levels of three experiments (n=3) as shown in panel A. normalized to total ERK1/2 levels. C. Bar diagram of LC3 II levels of three experiments (n=3) as shown in panel A normalized to beta actin levels. D. Representative confocal images of STHdhQ7/7, STHdhQ111/111, STHdhQ111 /111Grb2si, STHdhQ111/111 Scrmbsi cells transfected with dual tagged GFP-LC3-mCherry at 24hrs, 48hrs, 72hrs and 96hrs timepoints. E. Bar diagram of ratio of number of green/red to free red vesicles in each cell of D (n≥20). F. Representative western blot showing LC3 and beta actin levels of STHdhQ7/7, STHdhQ111/111 and STHdhQ111 /111Grb2si cells treated or untreated with 100nM bafilomycinA1, G. Bar diagram of three independent (n=3) experiments of F. of LC3II levels normalized to beta actin levels.We also checked the temporal distribution of LC3 in lysosomal vesicles using a LC3-GFP-mCherry construct which was supposed to emit only free red signals on merger with lysosomes. STHdhQ7/7 cells, up to 48hrs timepoint, showed predominantly green signals that turned red after 72hrs. STHdhQ111/111 cells, on the other hand, showed green/red to free red transition of signal within 48hrs. In STHdhQ111/111 Grb2si cells the lysosomal merger took place very late and only at 96hrs the vesicles became red (GFP quenched). The STHdhQ111/111 scrmbsi cells showed similar results as STHdhQ111/111 cells (Fig: 5D, E). This result showed that STHdhQ111/111 Grb2si cells were not efficient in lysosomal fusion as compared to the STHdhQ111/111 cells, suggests that Grb2 helps in autosomal-lysosomal fusion. We also confirmed this observation by treating the cells with a well known lysosomal inhibitor BafilomycinA1. BafilomycinA1 treatment showed increased LC3II levels in both STHdhQ7/7 and STHdhQ111 /111cells (Figure 5 F, G; n=3) due to inhibition in lysosomal fusion. But in STHdhQ111/111 Grb2si cells no significant change in LC3II levels (Figure 5 F, G; n=3) were observed after bafilomycinA1 treatment, indicating inability of these cells in lysosomal fusion with autophagosomes.We checked the survivability of the STHdhQ7/7, STHdhQ111/111 and STHdhQ111/111 Grb2si cells using MTT assay (Figure S3 in File S2). The STHdhQ7/7 cells showed maximum survivability followed by STHdhQ111/111 cells and the Grb2si cells showed least survivability amongst the three, possibly due to some effects of knock-down mechanism of Grb2, which also induced growth retardation. Grb2 transfection increased the survivability in all three cases (Figure S3 in File S2). The Dsred transfected cells showed lower survivability compared to normal cells in all cases, this was possibly due to Lipofectamine induced stress in the cells.
Endogenous mutant Htt and Grb2 colocalize with autophagosome
To ascertain the nature of the vesicles where endogenous Htt and Grb2 were colocalized, we stained STHdhQ7/7 and STHdhQ111/111 with specific monoclonal antibodies against the proteins and secondary antibodies tagged with alexa 488 or alexa546, respectively. The single stained cells with anti-Htt antibody showed thread like structures in STHdhQ111/111 but in STHdhQ7/7 cells it showed punctate distribution spread over the cells (Figure S4 in File S2). When stained with anti-Grb2 antibody alone, both the cells showed cytoplasmic distribution with much intense vesicular structures (Figure S4 in File S2). Simultaneous staining of both Htt and Grb2 showed colocalization of the two in STHdhQ111/111 cells but no such colocalization could be observed in STHdhQ7/7 cells (Figure 6 C, D ; ICQ and Pearson’s correlation coefficient values were significantly higher, p<0.01, n=20, Figure S5 in File S2). Further, taking a cue from western blot results, the cells were stained with the autophagosome marker anti-LC3 antibody. Both Htt and Grb2 were separately found to be colocalized with LC3 in STHdhQ111/111 cells but none of them were found to get colocalized with LC3 in STHdhQ7/7 cells (ICQ and Pearson’s correlation coefficient values were significantly higher, for Grb2 and LC3, Figure 6 A, B ICQ p<0.05 and Pearson’s correlation coefficient p<0.001, n=20 and for Htt and LC3, Figure 6 E, F Pearson’s correlation coefficient p<0.01, n=20; see also Figure S5 in File S2). The Htt-Grb2 colocalized structures were also found to be in colocalization with LC3 in STHdhQ111/111 cells in triple protein stained cells (Figure 6 H).
Figure 6
Endogenous Htt and Grb2 is localized to Autophagosome in STHdhQ111/111 cell
Double stained confocal images of Htt, Grb2 and LC3 in STHdhQ7/7 and STHdhQ111/111 cells. A & B. Grb2 & LC3 in, C & D Htt & Grb2, E&F. Htt & LC3 G&H triple stained images in STHdhQ7/7 and STHdhQ111/111 cells respectively.
Endogenous Htt and Grb2 is localized to Autophagosome in STHdhQ111/111 cell
Double stained confocal images of Htt, Grb2 and LC3 in STHdhQ7/7 and STHdhQ111/111 cells. A & B. Grb2 & LC3 in, C & D Htt & Grb2, E&F. Htt & LC3 G&H triple stained images in STHdhQ7/7 and STHdhQ111/111 cells respectively.We noticed changes in endogenous Htt distribution in different conditions. In STHdhQ7/7 cells Htt had punctate distribution throughout the cell whereas in STHdhQ111/111 cells some fibril like structures were also observed in addition to the puncta. Surprisingly in STHdhQ111 /111Grb2si cells these fibrillar structures were not observed (Figure S6 in File S2). When Grb2 was overexpressed by transfection with Grb2-Dsred, STHdhQ7/7 showed no co-localization with Grb2-Dsred vesicles, whereas STHdhQ111/111 showed co-localization of endogenous Htt with Grb2-Dsred vesicle (Figure S5 in File S2). In case of STHdhQ111 /111Grb2si cells also this co-localization was observed (Figure S6 in File S2).
Discussion
In the present study, the cellular fate of Grb2Htt interaction is checked. For the first time, it is demonstrated that endogenous Grb2 is upregulated in HD R6/2 mouse model as well as in a cell model STHdhQ111/111, precluding the possibility of secondary effects. Expectedly, overexpression of mutant Htt exon1 also increases Grb2 protein levels in Neuro2A cells. While investigating the mechanism of Grb2 upregulation in HD models, quite serendipitously it is seen that the transcription factor Foxd3 binds to the Grb2 upstream promoter region and activates its expression. Foxd3, which is upregulated in both R6/2 mice striatum and STHdhQ111/111 cells, hence upregulates Grb2 expression. The phosphorylation of downstream effectors of Grb2 in MAPK signaling pathway are found to be downregulated in STHdhQ111/111 cells. It is reported that downregulation of ERK1/2 phosphorylation increases the levels of Foxd3 [33]. This observation suggests the existence of a feedback loop in the regulation of Grb2, Foxd3 and ERK1/2 phosphorylation.In an attempt to mimic a similar condition by overexpressing Grb2 (fusion product Grb2-Dsred) along with mutant Htt exon1 (as 145QHttex1GFP) in Neuro2A cells, Grb2 is found to reduce the number of cells having Htt aggregates as evident from the increase in mobility of Htt in presence of Grb2. Grb2 is known to activate Ras and subsequent effectors of MAPK signaling pathway [6]. Grb2 is also known to be involved in coated pit formation and EGF receptor internalization and endocytosis [34]. For the first time, we could demonstrate with clear evidences that Grb2 can have a chaperone like activity inside the cell. Grb2 is located inside endocytic vesicles and Htt exon1, when overexpressed, is found to colocalize with these Grb2 containing vesicles in Neuro2A cells. Endogenous Htt is found to colocalize with Grb2 in STHdhQ111/111 cells whereas no such colocalization is observed in the control cells. Earlier the Grb2-Htt interaction was reported to be regulated by EGFR activation [5]. We found that Htt can be pulled down by Grb2 only in case of STHdhQ111/111 cells, indicating that the association of Grb2 is directly correlated with the mutant form of Htt independent of EGFR activation. This polyQ length dependence of Grb2 interaction with Htt might have clinical implications.Based on the observation that Grb2 is upregulated in STHdhQ111/111 cells, it is expected to activate Ras and enhance phosphorylation of MAPK effecter ERK1/2. On the contrary, phospho ERK1/2 level is found to be downregulated in STHdhQ111/111 cells. We report that the excess load of Grb2 in STHdhQ111/111 cells is redirected towards autophagic removal of mutant Htt and hence phospho ERK1/2 level is diminished instead. STHdhQ111/111 cells show upregulation of autophagy related marker proteins LC3 and Beclin1 and experiments with lysosomal inhibitor further validates this. In the same system LC3 is found to be colocalized with Htt and Grb2 complex. At this context a novel function of Grb2 as a ‘scavenger’ molecule may not be ruled out.This involvement of Grb2 in the clearance of the toxic load of Htt is confirmed by knocking down Grb2 in STHdhQ111/111 cell which show downregulation of LC3 and delay in fusion of LC3 containing vesicles to lysosomes. Involvement of Grb2 in fusion of autophagic vesicles to lysosomes is also intriguing. The two novel functions of Grb2, like a chaperone and a scavenger protein, to specifically clear the toxic effect and load of mutant Htt, is of enormous importance in the context of HD pathology since the levels of endogenous Grb2 is naturally elevated in HD models. These emerging roles of Grb2 can be viewed as a natural protective mechanism of the cell to combat the disease.So, according to our findings Grb2 preferentially interacts with mutant Htt in STHdhQ111/111 cells and this interaction acts as a competitor of Grb2-SOS1 interaction. As a result MAPK signaling is downregulated in these cells, as evident from lower phospho ERK1/2 levels in STHdhQ111/111. This in turn activates the Foxd3 levels in the cell which regulates the Grb2 levels. Upregulated Grb2 helps Htt clearance via autophagy-lysosomal pathway.Details of experimental procedures.(PDF)Click here for additional data file.Supporting Figures (Figure S1- Figure S6) and Tables (Table S1 – Table S3).
Table S1, Table showing primer sequences used for Realtime PCR experiments and molecular cloning. Table S2, List of Transcription Factors From MATCH output with known expressions in HD. Table S3, List of Transcription Factors with unknown expressions in HD. Figure S1, Representative confocal image of neuro2a cell, co-transfected with Grb2 dsred and 145QHttexon1 and immunostained with Rab7 antibody and nuclear stained with DAPI. Figure S2, Bar diagram of the mean optical densities of bands obtained in three independent filter retardation assay (n=3) with neuro2A cells transfected with Grb2-Dsred; 145Qhttex1 GFP and Grb2-Dsred; 145Q httex1 GFP; and 145Q Httex1 and Dsred. In all cases total input loads were 20μg and 40μg. Figure S3, MTT assay result of three independent (n=3) experiments of STHdhQ7/7 and STHdhQ111/111 and STHdhQ111/111 Grb2 si cells and transfected with Grb2-dsred and Dsred respectively. Figure S4, Representative confocal images showing endogenous distribution of Htt, Grb2 and LC3 in STHdhQ7/7 and STHdhQ111/111 cells. Figure S5, A. ICQ analysis of images in B (n=20) B. Pearson’s correlation coefficient of images in B (n=20) of Fig.6. Figure S6, E. Representative confocal images of endogenous Htt expression in STHdhQ7/7 and STHdhQ111/111 cells transfected with DsredC1 empty vector and Grb2 dsred. F. Endogenous Htt expression in STHdhQ111/111 Grb2 si cells , STHdhQ111/111Grb2 si cells transfected with Grb2 dsred and Dsred C1 vector.(PDF)Click here for additional data file.
Authors: V C Wheeler; J K White; C A Gutekunst; V Vrbanac; M Weaver; X J Li; S H Li; H Yi; J P Vonsattel; J F Gusella; S Hersch; W Auerbach; A L Joyner; M E MacDonald Journal: Hum Mol Genet Date: 2000-03-01 Impact factor: 6.150
Authors: F Trettel; D Rigamonti; P Hilditch-Maguire; V C Wheeler; A H Sharp; F Persichetti; E Cattaneo; M E MacDonald Journal: Hum Mol Genet Date: 2000-11-22 Impact factor: 6.150
Authors: Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong Journal: Autophagy Date: 2021-02-08 Impact factor: 13.391